Objective: Although coronavirus disease-2019 (COVID- 19) is seen in all age groups, the disease may progress more severely in adults with geriatric patients and comorbidities. We aimed to determine mortality rates and factors that may affect mortality by comparing the demographic, clinical, laboratory and radiological characteristics of different geriatric age groups. Material and Methods: A total of 444 COVID-19 intensive care unit (ICU) patients aged ≥65 years who were diagnosed with COVID-19 (real-time polymerase chain reaction positive) were included in the study. The patients were classified into 3 groups according to their age: younger-aged (65-74 years old), middle-aged (75-84 years old) and advanced-aged (≥85 years old) and the groups were compared. Results: The most common hospital admission symptom of total of 444 (73.2%) patients was dyspnoea. There was a statistical difference between genders in three groups (p<0.001). There was no difference between the mortality rates of the 3 groups (p=0.097). According to multiple logistic regression analysis, age ≥85 years, lactate dehydrogenase (LDH), procalcitonin and myalgia/joint pain were determined to be the risk factors that may affect mortality (p values 0.01, 0.025, 0.033 and 0.01, respectively). Conclusion: In geriatric COVID-19 ICU patients, advanced-age (≥85 years), male gender, laboratory parameters (e.g., interleukin-6, ferritin, procalcitonin, LDH) and, dyspnoea are the risk factors that increased mortality. Mortality rate was similar in geriatric groups.
Keywords: Geriatry; COVID-19; intensive care unit; mortality
Amaç: Koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)], tüm yaş gruplarında görülse de ileri yaş ve komorbiditeleri olan erişkinlerde hastalık daha ağır seyredebilir. Farklı geriatrik yaş gruplarının demografik, klinik, laboratuvar ve radyolojik özelliklerini karşılaştırarak, mortalite oranlarını ve mortaliteyi etkileyebilecek faktörleri belirlemeyi amaçladık. Gereç ve Yöntemler: Çalışmaya, COVID-19 (gerçek zamanlı polimeraz zincir reaksiyonu pozitif) tanısı almış 65 yaş ve üzeri 444 COVID-19 yoğun bakım ünitesi (YBÜ) hastası dâhil edildi. Hastalar yaşlarına göre genç yaşlı (65-74), orta yaşlı (75-84) ve ileri yaşlı (≥85) olmak üzere 3 gruba ayrıldı ve gruplar karşılaştırıldı. Bulgular: Toplam 444 hastanın en sık hastaneye başvuru semptomu dispne (%73,2) idi. Üç grup arasında cinsiyetler açısından istatistiksel fark vardı (p<0,001). Üç grubun ölüm oranları arasında fark yoktu (p=0,097). Çoklu lojistik regresyon analizine göre yaş ≥85, laktat dehidrogenaz (LDH), prokalsitonin ve miyalji/eklem ağrısı mortaliteyi etkileyebilecek risk faktörleri olarak belirlendi (p değerleri sırasıyla 0,01, 0,025, 0,033 ve 0,01). Sonuç: Geriatrik COVID-19 YBÜ'de ileri yaş (≥85), erkek cinsiyet, laboratuvar parametreleri (örneğin interlökin-6, ferritin, prokalsitonin, LDH) ve dispne mortaliteyi artıran risk faktörleridir. Mortalite oranı geriatri gruplarda benzerdi.
Anahtar Kelimeler: Geriatri; COVID-19; yoğun bakım ünitesi; ölüm
- Republic of Turkey Ministry of Covid-19 [Internet]. © 2022 T.C. Sağlık Bakanlığı. Information Page. Available from: [Link]
- Trevisan C, Noale M, Prinelli F, Maggi S, Sojic A, Bari MD, et al. Age-related changes in clinical presentation of Covid-19: the EPICOVID19 web-based survey. Eur J Intern Med. 2021;86:41-7. [Crossref] [PubMed] [PMC]
- Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020;65(5):533-46. [Crossref] [PubMed] [PMC]
- Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-8. [Crossref] [PubMed] [PMC]
- Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-6. [Crossref] [PubMed]
- Aggarwal S, Telles NG, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl). 2020;7(2):91-9. [Crossref] [PubMed]
- Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;24;8(1):e35. [PubMed] [PMC]
- Görgülü Ö, Duyan M. Effects of comorbid factors on prognosis of three different geriatric groups with COVID-19 diagnosis. SN Compr Clin Med. 2020;(12):2583-94. [Crossref] [PubMed] [PMC]
- Soytaş RB, Ünal D, Arman P, Veysel Suzan, Gedik TE, Can G, et al. Factors affecting mortality in geriatric patients hospitalized with COVID-19. Turk J Med Sci. 2021;51(2):454-63. [Crossref] [PubMed] [PMC]
- T.C. Aile, Çalışma ve Sosyal Hizmetler Bakanlığı Engelli ve Yaşlı Hizmetleri Genel Müdürlüğü. Yaşlı nüfusun demografik değişimi (2020). [Link]
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescottet HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA. 2020;324(8):782-93. [Crossref] [PubMed]
- Norman DC. Fever in the elderly. Clin Infect Dis. 2000;31(1):148-51. [Crossref] [PubMed]
- Pajo AT, Espiritu AI, Apor ADAO, Jamora RDG. Neuropathologic findings of patients with COVID-19: a systematic review. Neurol Sci. 2021;42(4):1255-66. [Crossref] [PubMed] [PMC]
- Dai SP, Zhao X, Wu JH. Effects of comorbidities on the elderly patients with COVID-19: clinical characteristics of elderly patients infected with COVID-19 from Sichuan, China. J Nutr Health Aging. 2021;25(1):18-24. [Crossref] [PubMed] [PMC]
- Duru S. COVID-19 in elderly patients. Eurasian J Pulmonol. 2020;22(4):76-81. [Crossref]
- Azzolina D, Magnani C, Gallo E, Ferrante D, Gregori D. [Gender and age factors affecting the mortality during the COVID-19 epidemic in Italy]. Epidemiol Prev 2020;44(5-6 Suppl 2):252-9. [PubMed]
- Magnani C, Azzolina D, Gallo E, Ferrante D, Gregori D. How large was the mortality increase directly and indirectly caused by the COVID-19 epidemic? An analysis on all-causes mortality data in Italy. Int J Environ Res Public Health. 2020;15;17(10):3452. [Crossref] [PubMed] [PMC]
- Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020;8:36. [Crossref] [PubMed] [PMC]
- Luo X, Zhou W, Yan X, Guo T, Wang B, Xia H. Prognostic value of C-reactive protein in patients with coronavirus 2019. Clin Infect Dis. 2020;19;71(16):2174-9. [Crossref] [PubMed] [PMC]
- Liu F, Li L, Xu MD, Luo D, Zhu Y, Liet B. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370. [Crossref] [PubMed] [PMC]
.: Process List